Skip to content

Clinical trials

Phase 2 Esophageal Neoplasms trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Esophageal Neoplasms Phase: Phase 2 Country / region: Japan Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20061
20081
20101
20171
20203
20212
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Active, not recruiting3
Unknown status3
Recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hamamatsu University2
University of Yamanashi2
Astellas Pharma Global Development, Inc.1
AstraZeneca1
Bayer1
Bristol-Myers Squibb1
Daiichi Sankyo1
Janssen Pharmaceutical K.K.1
Merck Sharp & Dohme LLC1
Millennium Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Esophageal Neoplasms13
Stomach Neoplasms7
Pancreatic Neoplasms4
Breast Neoplasms3
Carcinoma, Non-Small-Cell Lung3
Colorectal Neoplasms3
Endometrial Neoplasms3
Gallbladder Neoplasms3
Ovarian Neoplasms3
Urinary Bladder Neoplasms3

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.